Elsayed Balbaa, Ahmed A Ibrahim, Mohammad Bazzazeh, Shehroze Tabassum, Shrouk Ramadan, Ahmed Farid Gadelmawla, Abdelrahman Elshimy, Obieda Altobaishat, Mohamed Abuelazm
{"title":"经皮心脏手术前非禁食与禁食:随机对照试验的系统回顾和荟萃分析。","authors":"Elsayed Balbaa, Ahmed A Ibrahim, Mohammad Bazzazeh, Shehroze Tabassum, Shrouk Ramadan, Ahmed Farid Gadelmawla, Abdelrahman Elshimy, Obieda Altobaishat, Mohamed Abuelazm","doi":"10.1186/s13741-024-00485-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Despite the absence of scientific evidence, fasting before percutaneous cardiac catheterization is still recommended to minimize complications. This systematic review and meta-analysis aimed to compare the outcomes of non-fasting protocols in patients undergoing percutaneous cardiac procedures.</p><p><strong>Materials and methods: </strong>A systematic search of PubMed, Scopus, WOS, Embase, and Cochrane was conducted until September 2024. Dichotomous outcomes were pooled using risk ratio (RR), while continuous outcomes were pooled using standardized mean difference (SMD).</p><p><strong>Prospero id: </strong>CRD42024586147.</p><p><strong>Results: </strong>Five RCTs with 2034 patients were included. There was no significant difference between both groups regarding patient satisfaction score [SMD - 0.65, 95% CI (- 1.39, 0.09), P = 0.08], intra/postoperative aspiration (RR 1.00, 95% CI [0.20, 4.96], P = 1.00), postprocedural pneumonia (RR 0.60, 95% CI [0.14, 2.51], P = 0.49), emergency endotracheal intubation (RR 0.99, 95% CI [0.10, 9.51], P = 1.00), nausea/vomiting (RR 0.89, 95% CI [0.46, 1.76], P = 0.75), anti-emetic use (RR 0.49, 95% CI [0.24, 1.03], P = 0.06), hypoglycemia (RR 0.74, 95% CI [0.43, 1.28], P = 0.28), and the need for inotrope/vasopressor therapy (RR 1.03, 95% CI [0.81, 1.30], P = 0.82). However, the non-fasting approach significantly decreased the sensation of tiredness/fatigue (SMD - 0.31 with 95% CI [- 0.51, - 0.11], P < 0.001).</p><p><strong>Conclusion: </strong>The non-fasting protocol demonstrated comparable efficacy, safety, and overall satisfaction to the conventional fasting approach. REVIEW REGISTRATION : PROSPERO CRD42024586147.</p>","PeriodicalId":19764,"journal":{"name":"Perioperative Medicine","volume":"14 1","pages":"24"},"PeriodicalIF":2.0000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869692/pdf/","citationCount":"0","resultStr":"{\"title\":\"Non-fasting versus fasting before percutaneous cardiac procedures: a systematic review and meta-analysis of randomized controlled trials.\",\"authors\":\"Elsayed Balbaa, Ahmed A Ibrahim, Mohammad Bazzazeh, Shehroze Tabassum, Shrouk Ramadan, Ahmed Farid Gadelmawla, Abdelrahman Elshimy, Obieda Altobaishat, Mohamed Abuelazm\",\"doi\":\"10.1186/s13741-024-00485-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objective: </strong>Despite the absence of scientific evidence, fasting before percutaneous cardiac catheterization is still recommended to minimize complications. This systematic review and meta-analysis aimed to compare the outcomes of non-fasting protocols in patients undergoing percutaneous cardiac procedures.</p><p><strong>Materials and methods: </strong>A systematic search of PubMed, Scopus, WOS, Embase, and Cochrane was conducted until September 2024. Dichotomous outcomes were pooled using risk ratio (RR), while continuous outcomes were pooled using standardized mean difference (SMD).</p><p><strong>Prospero id: </strong>CRD42024586147.</p><p><strong>Results: </strong>Five RCTs with 2034 patients were included. There was no significant difference between both groups regarding patient satisfaction score [SMD - 0.65, 95% CI (- 1.39, 0.09), P = 0.08], intra/postoperative aspiration (RR 1.00, 95% CI [0.20, 4.96], P = 1.00), postprocedural pneumonia (RR 0.60, 95% CI [0.14, 2.51], P = 0.49), emergency endotracheal intubation (RR 0.99, 95% CI [0.10, 9.51], P = 1.00), nausea/vomiting (RR 0.89, 95% CI [0.46, 1.76], P = 0.75), anti-emetic use (RR 0.49, 95% CI [0.24, 1.03], P = 0.06), hypoglycemia (RR 0.74, 95% CI [0.43, 1.28], P = 0.28), and the need for inotrope/vasopressor therapy (RR 1.03, 95% CI [0.81, 1.30], P = 0.82). However, the non-fasting approach significantly decreased the sensation of tiredness/fatigue (SMD - 0.31 with 95% CI [- 0.51, - 0.11], P < 0.001).</p><p><strong>Conclusion: </strong>The non-fasting protocol demonstrated comparable efficacy, safety, and overall satisfaction to the conventional fasting approach. REVIEW REGISTRATION : PROSPERO CRD42024586147.</p>\",\"PeriodicalId\":19764,\"journal\":{\"name\":\"Perioperative Medicine\",\"volume\":\"14 1\",\"pages\":\"24\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869692/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Perioperative Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13741-024-00485-6\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perioperative Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13741-024-00485-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:尽管缺乏科学证据,经皮心导管置入术前禁食仍被推荐以减少并发症。本系统综述和荟萃分析旨在比较非禁食方案在经皮心脏手术患者中的结果。材料与方法:系统检索PubMed、Scopus、WOS、Embase和Cochrane,检索截止至2024年9月。二分类结果采用风险比(RR)合并,连续结果采用标准化平均差(SMD)合并。普洛斯彼罗id: CRD42024586147。结果:纳入5项随机对照试验,共2034例患者。两组之间没有显著性差异对病人满意度得分(SMD - 0.65, 95%可信区间(- 1.39,0.09),P = 0.08),内部/术后愿望(相对危险度1.00,95%可信区间[0.20,4.96],P = 1.00), postprocedural肺炎(相对危险度0.60,95%可信区间[0.14,2.51],P = 0.49),紧急气管插管(相对危险度0.99,95%可信区间[0.10,9.51],P = 1.00),恶心/呕吐(相对危险度0.89,95%可信区间[0.46,1.76],P = 0.75),止吐药使用(相对危险度0.49,95%可信区间[0.24,1.03],P = 0.06),低血糖(RR 0.74,95% CI [0.43, 1.28], P = 0.28),以及是否需要肌力/血管加压药物治疗(RR 1.03, 95% CI [0.81, 1.30], P = 0.82)。然而,非禁食方法显著降低了疲劳/疲劳的感觉(SMD - 0.31, 95% CI [- 0.51, - 0.11], P结论:非禁食方案与传统禁食方法具有相当的疗效、安全性和总体满意度。审核注册:prospero crd42024586147。
Non-fasting versus fasting before percutaneous cardiac procedures: a systematic review and meta-analysis of randomized controlled trials.
Background and objective: Despite the absence of scientific evidence, fasting before percutaneous cardiac catheterization is still recommended to minimize complications. This systematic review and meta-analysis aimed to compare the outcomes of non-fasting protocols in patients undergoing percutaneous cardiac procedures.
Materials and methods: A systematic search of PubMed, Scopus, WOS, Embase, and Cochrane was conducted until September 2024. Dichotomous outcomes were pooled using risk ratio (RR), while continuous outcomes were pooled using standardized mean difference (SMD).
Prospero id: CRD42024586147.
Results: Five RCTs with 2034 patients were included. There was no significant difference between both groups regarding patient satisfaction score [SMD - 0.65, 95% CI (- 1.39, 0.09), P = 0.08], intra/postoperative aspiration (RR 1.00, 95% CI [0.20, 4.96], P = 1.00), postprocedural pneumonia (RR 0.60, 95% CI [0.14, 2.51], P = 0.49), emergency endotracheal intubation (RR 0.99, 95% CI [0.10, 9.51], P = 1.00), nausea/vomiting (RR 0.89, 95% CI [0.46, 1.76], P = 0.75), anti-emetic use (RR 0.49, 95% CI [0.24, 1.03], P = 0.06), hypoglycemia (RR 0.74, 95% CI [0.43, 1.28], P = 0.28), and the need for inotrope/vasopressor therapy (RR 1.03, 95% CI [0.81, 1.30], P = 0.82). However, the non-fasting approach significantly decreased the sensation of tiredness/fatigue (SMD - 0.31 with 95% CI [- 0.51, - 0.11], P < 0.001).
Conclusion: The non-fasting protocol demonstrated comparable efficacy, safety, and overall satisfaction to the conventional fasting approach. REVIEW REGISTRATION : PROSPERO CRD42024586147.